Reflections on Jogee: overwhelming supervening act

The Supreme Court’s judgment in Jogee and Ruddock v The Queen1 substantially altered the criminal law’s approach to secondary liability. However, the judgment left numer- ous important issues unresolved. In particular, the circum- stances in which a secondary party is excused liability on the basis of an overwhelming supervening act (“OSA”) of the principal remains unclear. The Court of Appeal recently discussed OSA in Lanning and Camille,2 but it too left im- portant questions unanswered. In this article we examine this concept, which is being encountered with increasing frequency in practice

SYSTEMS-2: a randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma

SYSTEMS-2 is a randomised study of radiotherapy dose escalation for pain control in 112 patients with malignant pleural mesothelioma (MPM). Standard palliative (20Gy/5#) or dose escalated treatment (36Gy/6#) will be delivered using advanced radiotherapy techniques and pain responses will be compared at week 5. Data will guide optimal palliative radiotherapy in MPM

Does movement matter in people with back pain? Investigating 'atypical' lumbo-pelvic kinematics in people with and without back pain using wireless movement sensors

Background: Interventions for low back pain (LBP) commonly target 'dysfunctional' or atypical lumbo-pelvic kinematics in the belief that correcting aberrant movement improves patients' pain and activity outcomes. If atypical kinematic parameters and postures have a relationship to LBP, they could be expected to more prevalent in people with LBP compared to people without LBP (NoLBP). This exploratory study measured, defined and compared atypical kinematic parameters in people with and without LBP. Methods: Wireless inertial motion and EMG sensors were used to measure lumbo-pelvic kinematics during standing trunk flexion (range of motion (ROM), timing, sequence coordination, and extensor muscle activation) and in sitting (relative sitting position, pelvic tilt range) in a sample of 126 of adults without LBP and 140 chronic LBP subjects. Atypical movement was defined using the 10th/90th centiles of the NoLBP group. Mean differences and prevalence rates for atypical movement were calculated. Dichotomised pain scores for 'high-pain-on-bending' and 'high-pain-on-sitting' were tested for their association with atypical kinematic variables. Results: For standing flexion, significant mean differences, after adjusting for age and gender factors, were seen for the LBP group with (i) reduced ROM (trunk flexion (NoLBP 111o, LBP 93o, p <.0001), lumbar flexion (NoLBP 52o, LBP 46o, p <.0001), pelvic flexion (NoLBP 59o, LBP 48o, p <.0001), (ii) greater extensor muscle activation for the LBP group (NoLBP 0.012, LBP 0.25 p <.0001), (iii) a greater delay in pelvic motion at the onset of flexion (NoLBP - 0.21 s; LBP - 0.36 s, p = 0.023), (iv) and longer movement duration for the LBP group (NoLBP 2.28 s; LBP 3.18 s, p <.0001). Atypical movement was significantly more prevalent in the LBP group for small trunk (× 5.4), lumbar (× 3.0) and pelvic ROM (× 3.9), low FRR (× 4.9), delayed pelvic motion at 20o flexion (× 2.9), and longer movement duration (× 4.7). No differences between groups were seen for any sitting parameters. High pain intensity was significantly associated with small lumbar ROM and pelvic ROM. Conclusion: Significant movement differences during flexion were seen in people with LBP, with a higher prevalence of small ROM, slower movement, delayed pelvic movement and greater lumbar extensor muscle activation but without differences for any sitting parameter

Dietary treatment of Crohn’s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey

Background: Diet is strongly associated with the aetiology of Crohn’s Disease (CD) and exclusive enteral nutrition (EEN) is the primary induction treatment in paediatric CD. This study explored opinions around the use of EEN and alternative novel, solid food-based diets (SFDs) expressed by paediatric patients with CD, previously treated with EEN and their parents. Methods: This anonymous questionnaire surveyed families of CD patients treated with EEN over 1 year. Two questionnaire forms were completed; one asking the patients’ opinions and another referring to their main carer. This questionnaire explored participants’ demographic characteristics; acceptability of a repeat EEN course to treat a future flare (EEN repeat); their opinion on how difficult EEN would be compared to an example SFD; and their intention to participate in a future clinical trial assessing the therapeutic efficacy of an SFD in CD. Results: Forty-one families of CD patients were approached with 29 sending replies (71%). Most of our participants were positive on completing another EEN course, however the majority would choose an SFD alternative (Patients: 66, Parents:72%). Both patients and their parents rated EEN to be more difficult to adhere to compared to an example SFD (p < 0.05), and their ratings were strongly correlated (EEN:r = 0.83, SFD:r = 0.75, p < 0.001). The majority of our respondents would agree to participate in a clinical trial assessing an SFD’s effectiveness (Patients:79, Parents:72%) for the management of active CD. Conclusions: While patients with CD and their families would accept an EEN repeat, the majority would prefer an SFD alternative. CD families surveyed are supportive of the development of solid food-based dietary treatments

Spectroscopy of 19^{19}Ne for the thermonuclear 15^{15}O(α,γ\alpha,\gamma)19^{19}Ne and 18^{18}F(p,αp,\alpha)15^{15}O reaction rates

Uncertainties in the thermonuclear rates of the $^{15}$O($\alpha,\gamma$)$^{19}$Ne and $^{18}$F($p,\alpha$)$^{15}$O reactions affect model predictions of light curves from type I X-ray bursts and the amount of the observable radioisotope $^{18}$F produced in classical novae, respectively. To address these uncertainties, we have studied the nuclear structure of $^{19}$Ne over $E_{x} = 4.0 - 5.1$ MeV and $6.1 - 7.3$ MeV using the $^{19}$F($^{3}$He,t)$^{19}$Ne reaction. We find the $J^{\pi}$ values of the 4.14 and 4.20 MeV levels to be consistent with $9/2^{-}$ and $7/2^{-}$ respectively, in contrast to previous assumptions. We confirm the recently observed triplet of states around 6.4 MeV, and find evidence that the state at 6.29 MeV, just below the proton threshold, is either broad or a doublet. Our data also suggest that predicted but yet unobserved levels may exist near the 6.86 MeV state. Higher resolution experiments are urgently needed to further clarify the structure of $^{19}$Ne around the proton threshold before a reliable $^{18}$F($p,\alpha$)$^{15}$O rate for nova models can be determined.Comment: 5 pages, 3 figures, Phys. Rev. C (in press

Cancer and systemic inflammation: treat the tumour and treat the host

Determinants of cancer progression and survival are multifactorial and host responses are increasingly appreciated to have a major role. Indeed, the development and maintenance of a systemic inflammatory response has been consistently observed to confer poorer outcome, in both early and advanced stage disease. For patients, cancer-associated symptoms are of particular importance resulting in a marked impact on day-to-day quality of life and are also associated with poorer outcome. These symptoms are now recognised to cluster with one another with anorexia, weight loss and physical function forming a recognised cluster whereas fatigue, pain and depression forming another. Importantly, it has become apparent that these symptom clusters are associated with presence of a systemic inflammatory response in the patient with cancer. Given the understanding of the above, there is now a need to intervene to moderate systemic inflammatory responses, where present. In this context the rationale for therapeutic intervention using nonselective anti-inflammatory agents is clear and compelling and likely to become a part of routine clinical practice in the near future. The published literature on therapeutic intervention using anti-inflammatory agents for cancer-associated symptoms was reviewed. There are important parallels with the development of useful treatments for the systemic inflammatory response in patients with rheumatological disease and cardiovascular disease

Accuracy of Measuring Intensity Through Means of Repetition in Reserve in Trained College Females

poste

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation

peer-reviewedInnateDB (http://www.innatedb.com) is an integrated analysis platform that has been specifically designed to facilitate systems-level analyses of mammalian innate immunity networks, pathways and genes. In this article, we provide details of recent updates and improvements to the database. InnateDB now contains >196 000 human, mouse and bovine experimentally validated molecular interactions and 3000 pathway annotations of relevance to all mammalian cellular systems (i.e. not just immune relevant pathways and interactions). In addition, the InnateDB team has, to date, manually curated in excess of 18 000 molecular interactions of relevance to innate immunity, providing unprecedented insight into innate immunity networks, pathways and their component molecules. More recently, InnateDB has also initiated the curation of allergy- and asthma-related interactions. Furthermore, we report a range of improvements to our integrated bioinformatics solutions including web service access to InnateDB interaction data using Proteomics Standards Initiative Common Query Interface, enhanced Gene Ontology analysis for innate immunity, and the availability of new network visualizations tools. Finally, the recent integration of bovine data makes InnateDB the first integrated network analysis platform for this agriculturally important model organism.This work was supported by Genome BC through the Pathogenomics of Innate Immunity (PI2) project and by the Foundation for the National Institutes of Health and the Canadian Institutes of Health Research under the Grand Challenges in Global Health Research Initiative [Grand Challenges ID: 419]. Further funding was also provided by AllerGen grants 12ASI1 and 12B&B2. D.J.L. was funded in part during this project by a postdoctoral trainee award from the Michael Smith Foundation for Health Research (MSFHR). F.S.L.B. is a MSFHR Senior Scholar and R.E.W.H. holds a Canada Research Chair (CRC). Funding to enable bovine systems biology in InnateDB is provided by Teagasc [RMIS6018] and the Teagasc Walsh Fellowship scheme. IMEx is funded by the European Commission under the PSIMEx project [contract number FP7-HEALTH-2007-223411]. Funding for open access charge: Teagasc [RMIS6018]

The role of AGN in the colour transformation of galaxies at redshifts z~1

We explore the role of AGN in establishing and/or maintaining the bimodal colour distribution of galaxies by quenching their star-formation and hence, causing their transition from the blue to the red cloud. Important tests for this scenario include (i) the X-ray properties of galaxies in the transition zone between the two clouds and (ii) the incidence of AGN in post-starbursts, i.e. systems observed shortly after (<1Gyr) the termination of their star-formation. We perform these tests by combining deep Chandra observations with multiwavelength data from the AEGIS survey. Stacking the X-ray photons at the positions of galaxies (0.4<z<0.9) not individually detected at X-ray wavelengths suggests a population of obscured AGN among sources in the transition zone and in the red cloud. Their mean X-ray and mid-IR properties are consistent with moderately obscured low-luminosity AGN, Compton thick sources or a mix of both. Morphologies show that major mergers are unlikely to drive the evolution of this population but minor interactions may play a role. The incidence of obscured AGN in the red cloud (both direct detections and stacking results) suggests that BH accretion outlives the termination of the star-formation. This is also supported by our finding that post-starburst galaxies at z~0.8 and AGN are associated, in agreement with recent results at low-z. A large fraction of post-starbursts and red cloud galaxies show evidence for at least moderate levels of AGN obscuration. This implies that if AGN outflows cause the colour transformation of galaxies, then some nuclear gas and dust clouds either remain unaffected or relax to the central galaxy regions after the quenching their star-formation.Comment: Accepted for publication in MNRA